This Article Full Text Full Text (PDF) Correction (v67,p10624) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lavon, I. Articles by Siegal, T. Search for Related Content PubMed PubMed Citation Articles by Lavon, I. Articles by Siegal, T.

Novel Mechanism whereby Nuclear Factor B Mediates DNA Damage Repair through Regulation of O⁶-Methylguanine-DNA-Methyltransferase

¹ Leslie and Michael Gaffin Center for Neuro-Oncology and Departments of ² Neurology and ³ Pathology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

Requests for reprints: Iris Lavon, Department of Neurology, Leslie and Michael Gaffin Center for Neuro-Oncology, Ein Karem, P.O. Box 12000, 91120 Jerusalem, Israel. Phone: 972-2-677-7712; Fax: 972-2-677-7712; E-mail: irisl{at}hadassah.org.il.

O⁶-Methylguanine-DNA-methyltransferase (MGMT) and nuclear factor B (NF-B) are two key effectors associated with the development of resistance to alkylating agent–based chemotherapy. This prompted us to hypothesize that NF-B might be involved in MGMT regulation. Consistent with this hypothesis, we have discovered two putative NF-B binding sites within the MGMT promoter region and showed a specific and direct interaction of NF-B at each of these sites. Forced expression of the NF-B subunit p65 in HEK293 cells induced an increase in MGMT expression whereas addition of the NF-B super repressor NIB completely abrogated the induction. We also found a significant correlation between the extent of NF-B activation and MGMT expression in the glioma cell lines and the human glial tumors tested and showed that it was independent of MGMT promoter methylation. Our results are of potential clinical significance because we show that cell lines with ectopic p65 or high constitutive NF-B activity are less sensitive to nitrosourea treatment and that suppression of MGMT activity with O⁶-benzylguanine completely abolishes the chemoresistance acquired by NF-B. The findings of our study strongly suggest that NF-B plays a major role in MGMT regulation and that MGMT is most probably the major player in NF-B–mediated chemoresistance to alkylating agents. [Cancer Res 2007;67(18):8952–9]

This article has been cited by other articles:

				S. Everhard, J. Tost, H. El Abdalaoui, E. Criniere, F. Busato, Y. Marie, I. G. Gut, M. Sanson, K. Mokhtari, F. Laigle-Donadey, et al. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas Neuro-oncol, January 1, 2009; 11(4): 348 - 356. [Abstract] [Full Text] [PDF]

				Y. Zhao and R. J. Epstein Programmed Genetic Instability: A Tumor-Permissive Mechanism for Maintaining the Evolvability of Higher Species through Methylation-Dependent Mutation of DNA Repair Genes in the Male Germ Line Mol. Biol. Evol., August 1, 2008; 25(8): 1737 - 1749. [Abstract] [Full Text] [PDF]

				Correction: NF-{kappa}B in the Regulation of MGMT Gene Transcription Cancer Res., November 1, 2007; 67(21): 10624 - 10624. [Full Text] [PDF]